Amarin | AMRN - Pre Tax Profit


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

Amarin

Amarin reported $-14496000 in Pre-Tax Profit for its fiscal quarter ending in March of 2023.


Pre Tax Profit Change
AbbVie ABBV:US USD 5.08B 2.33B
Alnylam Pharmaceuticals ALNY:US USD -172362000 34.66M
Amarin AMRN:US USD -14496000 7.72M
AstraZeneca AZN:LN USD 3.71B 1.41B
Esperion Therapeutics ESPR:US USD -61719000 6.23M
Halozyme Therapeutics HALO:US USD 52.24M 18.55M
Intercept Pharmaceuticals ICPT:US USD -31881000 14.34M
Ionis Pharmaceuticals IONS:US USD -113000000 81M
Nektar Therapeutics NKTR:US USD -137081000 80.54M
Neurocrine Biosciences NBIX:US USD -103300000 221.2M